======= MSL3 ======= == Gene Information == * **Official Symbol**: MSL3 * **Official Name**: MSL complex subunit 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10943|10943]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N5Y2|Q8N5Y2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MSL3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MSL3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300609|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010]. * **UniProt Summary**: May be involved in chromatin remodeling and transcriptional regulation. May have a role in X inactivation. Component of the MSL complex which is responsible for the majority of histone H4 acetylation at 'Lys-16' which is implicated in the formation of higher-order chromatin structure. Specifically recognizes histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex. {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20657587, ECO:0000269|PubMed:20943666, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22547026}. |MRG| |Tudor-knot| |MSL complex| |histone H2A acetylation| |NuA4 histone acetyltransferase complex| |histone H4-K16 acetylation| |histone acetyltransferase complex| |histone deacetylation| |protein deacetylation| |histone H4 acetylation| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |methylated histone binding| |protein deacylation| |macromolecule deacylation| |chromatin organization involved in regulation of transcription| |negative regulation of gene expression, epigenetic| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |gene silencing| |protein acylation| |regulation of gene expression, epigenetic| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.28| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.26| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.08| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.97| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.97| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-1.91| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-1.91| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.85| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.83| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.81| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.8| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.78| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.76| |[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.75| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.74| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-1.73| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/683 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/25| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/14| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2273 * **Expression level (log2 read counts)**: 5.55 {{:chemogenomics:nalm6 dist.png?nolink |}}